This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Early Bird pricing expires in:

  • 00
  • 00
  • 00
  • 00
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital


Present in-person to an audience of investors, life science leaders and potential partners at BIO-Europe Spring.

Review the information below to learn more about what is included in an in-person presentation

Benefits of an in-person presentation

  • Increased visibility: Raise your company's profile and generate interest among active BD executives, top-tier VCs, pharma and private equity investors attending BIO-Europe Spring.
  • Promote your company globally: Put your licensable assets on the opportunity map to the international attendees, which represent over 55 countries.
  • Generate interest before your in-person presentation:  Submit a pre-recorded presentation that will be available for on-demand viewing by registered attendees up to three weeks prior to the event, and throughout the conference.
  • More one-to-one meetings: Your presentation in partneringONE® will include a link for attendees to schedule one-to-one meetings with your company virtually and when you are onsite in Basel.

Presentation Options

Biotech Company Presentation

In this track, biotech companies can seek partnership for their products, initiate strategic alliances and tap into the global financing network.

Midsize Pharma Presentation

Find your perfect fit partners and plan for the future.

Next Generation Presentation

This track is the most direct way for early stage projects and small entrepreneurial companies to get their innovative asset or idea directly in front of potential partners.

Academic Innovators Presentation

Academic researchers and technology transfer offices can apply to present their asset or idea to funding and development partners.